Verastem's IPO

Verastem raised a round of funding on January 30, 2012. Investors include Public.

Verastem is a biopharmaceutical company focused on discovering and developing drugs that selectively target cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metasta…

Articles about Verastem's IPO: